Aurora Cannabis (ACB) Competitors $5.21 -0.09 (-1.70%) Closing price 04:00 PM EasternExtended Trading$5.24 +0.04 (+0.67%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACB vs. CALT, OCUL, AMPH, AUPH, MLYS, RCUS, ARDX, NTLA, PAHC, and COLLShould you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Calliditas Therapeutics AB (publ) (CALT), Ocular Therapeutix (OCUL), Amphastar Pharmaceuticals (AMPH), Aurinia Pharmaceuticals (AUPH), Mineralys Therapeutics (MLYS), Arcus Biosciences (RCUS), Ardelyx (ARDX), Intellia Therapeutics (NTLA), Phibro Animal Health (PAHC), and Collegium Pharmaceutical (COLL). These companies are all part of the "pharmaceutical products" industry. Aurora Cannabis vs. Calliditas Therapeutics AB (publ) Ocular Therapeutix Amphastar Pharmaceuticals Aurinia Pharmaceuticals Mineralys Therapeutics Arcus Biosciences Ardelyx Intellia Therapeutics Phibro Animal Health Collegium Pharmaceutical Calliditas Therapeutics AB (publ) (NASDAQ:CALT) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, community ranking, media sentiment, earnings, dividends and profitability. Do analysts rate CALT or ACB? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Calliditas Therapeutics AB (publ) 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67 Which has more volatility & risk, CALT or ACB? Calliditas Therapeutics AB (publ) has a beta of 1.77, meaning that its stock price is 77% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.94, meaning that its stock price is 94% more volatile than the S&P 500. Which has higher valuation and earnings, CALT or ACB? Calliditas Therapeutics AB (publ) has higher revenue and earnings than Aurora Cannabis. Calliditas Therapeutics AB (publ) is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCalliditas Therapeutics AB (publ)$1.60B0.74-$43.96M-$1.85-21.62Aurora Cannabis$320.81M0.91-$48.62M$0.05104.20 Is CALT or ACB more profitable? Aurora Cannabis has a net margin of 0.42% compared to Calliditas Therapeutics AB (publ)'s net margin of -30.18%. Aurora Cannabis' return on equity of 0.59% beat Calliditas Therapeutics AB (publ)'s return on equity.Company Net Margins Return on Equity Return on Assets Calliditas Therapeutics AB (publ)-30.18% -212.04% -27.96% Aurora Cannabis 0.42%0.59%0.42% Does the MarketBeat Community favor CALT or ACB? Aurora Cannabis received 357 more outperform votes than Calliditas Therapeutics AB (publ) when rated by MarketBeat users. Likewise, 59.63% of users gave Aurora Cannabis an outperform vote while only 55.10% of users gave Calliditas Therapeutics AB (publ) an outperform vote. CompanyUnderperformOutperformCalliditas Therapeutics AB (publ)Outperform Votes2755.10% Underperform Votes2244.90% Aurora CannabisOutperform Votes38459.63% Underperform Votes26040.37% Does the media refer more to CALT or ACB? In the previous week, Aurora Cannabis had 1 more articles in the media than Calliditas Therapeutics AB (publ). MarketBeat recorded 2 mentions for Aurora Cannabis and 1 mentions for Calliditas Therapeutics AB (publ). Aurora Cannabis' average media sentiment score of 0.72 beat Calliditas Therapeutics AB (publ)'s score of 0.00 indicating that Aurora Cannabis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Calliditas Therapeutics AB (publ) 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of CALT or ACB? 2.8% of Calliditas Therapeutics AB (publ) shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 2.2% of Calliditas Therapeutics AB (publ) shares are owned by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryAurora Cannabis beats Calliditas Therapeutics AB (publ) on 15 of the 18 factors compared between the two stocks. Get Aurora Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACB vs. The Competition Export to ExcelMetricAurora CannabisMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$292.88M$1.20B$5.42B$8.48BDividend YieldN/AN/A5.28%4.19%P/E Ratio104.2211.5426.7719.73Price / Sales0.9111.13425.34144.51Price / Cash26.3510.4038.2534.64Price / Book0.641.516.764.55Net Income-$48.62M-$54.34M$3.23B$248.13M7 Day Performance-5.27%-0.14%3.43%3.09%1 Month Performance7.64%-1.63%6.29%7.21%1 Year Performance-15.83%-32.99%26.62%9.29% Aurora Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACBAurora Cannabis0.3755 of 5 stars$5.21-1.7%N/A-14.7%$292.88M$320.81M104.221,340CALTCalliditas Therapeutics AB (publ)N/A$40.00flat$39.25-1.9%N/A$1.19B$1.60B-21.62180OCULOcular Therapeutix3.6629 of 5 stars$7.30+1.1%$16.25+122.6%+40.5%$1.16B$59.65M-5.53230Positive NewsAnalyst RevisionGap DownAMPHAmphastar Pharmaceuticals4.279 of 5 stars$24.47+1.1%$32.33+32.1%-38.9%$1.16B$730.66M8.161,620Positive NewsShort Interest ↑AUPHAurinia Pharmaceuticals3.416 of 5 stars$8.08-2.3%$11.50+42.3%+45.0%$1.09B$247.30M-53.86300Positive NewsMLYSMineralys Therapeutics2.8393 of 5 stars$15.96-2.2%$38.00+138.1%+23.2%$1.04BN/A-4.3828Positive NewsGap DownRCUSArcus Biosciences2.6384 of 5 stars$9.05+3.0%$25.67+183.8%-40.4%$957.73M$141M-2.87500News CoverageShort Interest ↑Gap UpARDXArdelyx4.6559 of 5 stars$3.97+0.3%$10.39+161.7%-45.8%$949.84M$361.71M-24.8190Gap DownNTLAIntellia Therapeutics4.5995 of 5 stars$9.16-3.2%$36.90+302.8%-67.3%$948.82M$45.57M-1.68600PAHCPhibro Animal Health3.6867 of 5 stars$23.24+1.0%$20.00-13.9%+39.4%$942.01M$1.19B48.421,860Positive NewsCOLLCollegium Pharmaceutical4.1375 of 5 stars$28.86+0.1%$43.80+51.8%-11.3%$927.33M$664.28M12.44210Positive News Related Companies and Tools Related Companies Calliditas Therapeutics AB (publ) Competitors Ocular Therapeutix Competitors Amphastar Pharmaceuticals Competitors Aurinia Pharmaceuticals Competitors Mineralys Therapeutics Competitors Arcus Biosciences Competitors Ardelyx Competitors Intellia Therapeutics Competitors Phibro Animal Health Competitors Collegium Pharmaceutical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACB) was last updated on 6/2/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Gold analyst, Sean Brodrick, gave everyday investors an advance notice of this historic surge. When the bul...Weiss Ratings | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACB Stock Free ACB Stock Alerts